Please Wait.....
Report
Hyaluronic Acid in Healthcare: Global Markets
Market Research Report I 2025-09-17 I 114 Pages I BCC Research
Description
Report Scope
This report offers an overview of the global market for hyaluronic acid (HA) medical (or healthcare) products while also analyzing current market trends. The HA medical products covered in this report include HA dermal fillers, viscosupplements, dry eye treatments, ophthalmic viscoelastic devices (OVDs), regenerative products for wound care and musculoskeletal repair, anti-adhesion barriers and bulking agents for urology applications. The report covers only prescription products that may be used or recommended exclusively by qualified healthcare professionals in outpatient settings or during surgical procedures.
The report's estimates of the HA medical products market include global revenue ($ millions) for the base year of 2024, estimates for 2025 and data for the forecast period of 2025 through 2030. The report focuses on the major trends, challenges and opportunities in the market and vendor landscape. It also covers the new products, acquisitions and collaborations related to the market. The report also analyzes environmental, social and corporate governance (ESG) developments.
The report concludes with an analysis of the competitive landscape, which provides a ranking by market share of leading companies in each HA medical product market. There is also a section of profiles of the leading companies.
Report Includes
- An overview of the global market for hyaluronic acid (HA) medical products
- In-depth analysis of global market trends, featuring historical revenue data from 2022-2024, estimated figures for 2025, as well as forecasts for 2030, including projections of compound annual growth rates (CAGRs) through 2030
- Analysis of market opportunities with a review of Porter's Five Forces model and industry supply chain analysis, considering both micro- and macro environmental factors prevailing in the market
- Explanation of market drivers, restraints and other forces impacting the global market
- Coverage of evolving technologies, the current and future market potential, R&D activities, growth strategies, regulatory framework and reimbursement scenarios, and ESG trends of the market
- Identification of companies best positioned to meet this demand due to their proprietary technologies, mergers and acquisitions, and strategic initiatives
- Overview of sustainability trends and ESG developments, with emphasis on consumer attitudes, as well as the ESG risk ratings and practices of leading companies
- A relevant patent analysis, featuring key granted and published patents
- Profiles of the leading global companies, including AbbVie Inc., Galderma, Sanofi, Bioventus, IBSA Institut Biochimique S.A., and Fidia Farmaceutici S.p.A.
Executive Summary
Summary:
The global market for hyaluronic acid medical products is estimated to grow from $8 billion in 2025 to $10.5 billion by the end of 2030, at a compound annual growth rate (CAGR) of 5.7% from 2025 to 2030.
Hyaluronic acid (HA) is a naturally occurring glycosaminoglycan found in the skin, eyes, joints and connective tissues. It is known for its remarkable ability to retain water, maintain tissue hydration and provide structural support. In healthcare, its importance extends across multiple fields, including orthopedics for joint lubrication, ophthalmology for surgical procedures and dry eye treatments and dermatology for aesthetic enhancements and wound healing.
Leading companies working in the domain of HA medical products include AbbVie Inc., Anika Therapeutics Inc., Bioventus, Fidia Farmaceutici, Galderma, IBSA Institut Biochimique SA, Sanofi and Seikagaku Corp.
Table of Contents
Chapter 1 Executive Summary
Market Outlook
Scope of Report
Market Summary
Market Dynamics
Emerging Trends
Analysis by Segment
Analysis by Region
Conclusion
Chapter 2 Market Overview
Hyaluronic Acid
Analysis of Macroeconomic Factors
Economic Growth and Income Levels
Impact of the U.S. Tariffs
Demographic Trends
Porter's Five Forces Analysis
Bargaining Power of Buyers: Moderate to High
Bargaining Power of Suppliers: Moderate
Threat of New Entrants: Moderate
Threat of Substitutes: Moderate to High
Industry Rivalry: Moderate
Chapter 3 Market Dynamics
Market Dynamics
Market Drivers
Expanding Clinical Applications of Hyaluronic Acid
Innovation and Biotechnological Advancements
Trend Toward Minimally Invasive Procedures
Market Challenges
High Cost and Short-Lasting Effects of HA
Potential Adverse Reactions and Side Effects
Market Trends
Microbial Fermentation-based HA Production
Hybrid Formulations of HA
Chapter 4 Regulatory Landscape
Overview
U.S.
European Union
Japan
China
Chapter 5 Emerging Technologies and Developments
Hyaluronic Acid as a Drug Delivery Vehicle
Three-Dimensional Bioprinting
Enzyme-based Hyaluronic Acid Synthesis
Clinical Trial Analysis
Key Takeaways
Chapter 6 Market Segmentation Analysis
Segmentation Breakdown
Global Market for Hyaluronic Acid in Healthcare, by Product
Dermal Fillers
Viscosupplements
Ophthalmic Products
Regenerative and Anti-Adhesion Products
Bulking Agents for Urology Applications
Global Market for Hyaluronic Acid in Healthcare, by Source
Animal-derived HA
Microbial Fermentation
Geographic Breakdown
Global Market for Hyaluronic Acid in Healthcare, by Region
North America
Europe
Asia-Pacific
Middle East and Africa
South America
Chapter 7 Competitive Intelligence
Hyaluronic Acid Dermal Fillers
Key Takeaways
Market Share Analysis
Viscosupplements
Key Takeaways
Market Share Analysis
Ophthalmic Products
Regenerative and Anti-Adhesion Products
Bulking Agents for Urology Applications
Chapter 8 Sustainability in Hyaluronic Acid Market: An ESG Perspective
Introduction to ESG
Key ESG Issues Specific to Hyaluronic Acid Market
Environmental Impact of Single-Use Plastics in HA-based Treatments
Environmental Challenges of Large-Scale Microbial HA Production
Critical Role of Quality Control in Injectable HA Safety
Concluding Remarks
Chapter 9 Appendix
Methodology
Information Sources
Abbreviations
Company Profiles
ABBVIE INC.
ANIKA THERAPEUTICS INC.
BIOVENTUS
FERRING B.V.
FIDIA FARMACEUTICI S.P.A.
GALDERMA
IBSA INSTITUT BIOCHIMIQUE SA
MEDYTOX
MERZ PHARMA
NORDIC PHARMA
SANOFI
SANTEN PHARMACEUTICAL CO. LTD.
SEIKAGAKU CORP.
TEOXANE
URSAPHARM ARZNEIMITTEL GMBH
Emerging Start-ups/Market Disruptors
List of Tables
Summary Table : Global Market for Hyaluronic Acid Medical Products, by Region, Through 2030
Table 1 : Global Market for Hyaluronic Acid Medical Products, by Product, Through 2030
Table 2 : Global Nonsurgical Procedures Performed by Plastic Surgeons, 2022 versus 2023
Table 3 : Global Minimally Invasive Cosmetic Procedures, 2024 versus 2023
Table 4 : Commercially Available Hyaluronic Acid Dermal Fillers
Table 5 : Global Market for Dermal Fillers, by Region, Through 2030
Table 6 : Global Market for Viscosupplements, by Region, Through 2030
Table 7 : Commercially Available Three-Injection Regimen Viscosupplements
Table 8 : Commercially Available Single-Injection Regimen HA Viscosupplements
Table 9 : Commercially Available Five-Injection Regimen HA Viscosupplements
Table 10 : Global Market for Viscosupplements, by Regimen Type, Through 2030
Table 11 : Global Market for Ophthalmic Products, by Region, Through 2030
Table 12 : Global Market for Ophthalmic Products, by Type, Through 2030
Table 13 : Commercially Available Ophthalmic Viscosurgical Devices (OVDs)
Table 14 : Commercially Available Prescription Regenerative Solutions
Table 15 : Commercially Available Prescription Anti-Adhesion Products
Table 16 : Global Market for Regenerative and Anti-Adhesion Products, by Region, Through 2030
Table 17 : Commercially Available HA-Based Bulking Agents for Urology Applications
Table 18 : Global Market for Bulking Agents for Urology Applications, by Region, Through 2030
Table 19 : Medical Products Made of Animal-derived HA, 1997-2019
Table 20 : Global Market for Hyaluronic Acid Medical Products, by Hyaluronic Acid Source, Through 2030
Table 21 : Global Market for Hyaluronic Acid Medical Products, by Region, Through 2030
Table 22 : North American Market for Hyaluronic Acid Medical Products, by Product, Through 2030
Table 23 : North American Market for Hyaluronic Acid Medical Products, by Country, Through 2030
Table 24 : HA Injectable Aesthetic Procedures Performed, by Country, 2023
Table 25 : European Market for Hyaluronic Acid Medical Products, by Product, Through 2030
Table 26 : European Market for Hyaluronic Acid Medical Products, by Country, Through 2030
Table 27 : Asia-Pacific Market for Hyaluronic Acid Medical Products, by Product, Through 2030
Table 28 : Asia-Pacific Market for Hyaluronic Acid Medical Products, by Country, Through 2030
Table 29 : MEA Market for Hyaluronic Acid Medical Products, by Product, Through 2030
Table 30 : South American Market for Hyaluronic Acid Medical Products, by Product, Through 2030
Table 31 : Information Sources for this Report
Table 32 : Abbreviations Used in This Report
Table 33 : AbbVie Inc.: Company Snapshot
Table 34 : AbbVie Inc.: Financial Performance, FY 2023 and 2024
Table 35 : AbbVie Inc.: Product Portfolio
Table 36 : AbbVie Inc.: News/Key Developments, 2023 and 2024
Table 37 : Anika Therapeutics Inc.: Company Snapshot
Table 38 : Anika Therapeutics Inc.: Financial Performance, FY 2023 and 2024
Table 39 : Anika Therapeutics Inc.: Product Portfolio
Table 40 : Anika Therapeutics Inc.: News/Key Developments, 2023 and 2024
Table 41 : Bioventus: Company Snapshot
Table 42 : Bioventus: Financial Performance, FY 2023 and 2024
Table 43 : Bioventus: Product Portfolio
Table 44 : Bioventus: News/Key Developments, 2023
Table 45 : Ferring B.V.: Company Snapshot
Table 46 : Ferring B.V.: Financial Performance, FY 2023 and 2024
Table 47 : Ferring B.V.: Product Portfolio
Table 48 : Fidia Farmaceutici S.p.A.: Company Snapshot
Table 49 : Fidia Farmaceutici S.p.A.: Financial Performance, FY 2023 and 2024
Table 50 : Fidia Farmaceutici S.p.A.: Product Portfolio
Table 51 : Fidia Farmaceutici S.p.A.: News/Key Developments, 2023 and 2024
Table 52 : Galderma: Company Snapshot
Table 53 : Galderma: Financial Performance, FY 2023 and 2024
Table 54 : Galderma: Product Portfolio
Table 55 : Galderma: News/Key Developments, 2023 and 2024
Table 56 : IBSA Institut Biochimique SA: Company Snapshot
Table 57 : IBSA Institut Biochimique SA: Product Portfolio
Table 58 : IBSA Institut Biochimique SA: News/Key Developments, 2024
Table 59 : Medytox: Company Snapshot
Table 60 : Medytox: Financial Performance, FY 2023 and 2024
Table 61 : Medytox: Product Portfolio
Table 62 : Merz Pharma: Company Snapshot
Table 63 : Merz Pharma: Product Portfolio
Table 64 : Nordic Pharma: Company Snapshot
Table 65 : Nordic Pharma: Product Portfolio
Table 66 : Nordic Pharma: News/Key Developments, 2023-2025
Table 67 : Sanofi: Company Snapshot
Table 68 : Sanofi: Financial Performance, FY 2023 and 2024
Table 69 : Sanofi: Product Portfolio
Table 70 : Santen Pharmaceutical Co. Ltd.: Company Snapshot
Table 71 : Santen Pharmaceutical Co. Ltd.: Financial Performance, FY 2023 and 2024
Table 72 : Santen Pharmaceutical Co. Ltd.: Product Portfolio
Table 73 : Seikagaku Corp.: Company Snapshot
Table 74 : Seikagaku Corp.: Financial Performance, FY 2023 and 2024
Table 75 : Seikagaku Corp.: Product Portfolio
Table 76 : Seikagaku Corp.: News/Key Developments, 2024 and 2025
Table 77 : Teoxane: Company Snapshot
Table 78 : Teoxane: Product Portfolio
Table 79 : URSAPHARM Arzneimittel GmbH: Company Snapshot
Table 80 : URSAPHARM Arzneimittel GmbH: Product Portfolio
Table 81 : List of a Few Emerging Startups/Market Disruptors
List of Figures
Summary Figure : Global Market Shares of Hyaluronic Acid Medical Products, by Region, 2024
Figure 1 : Key Properties of Hyaluronic Acid
Figure 2 : Porter's Five Forces Analysis - Hyaluronic Acid in Healthcare Market
Figure 3 : Market Dynamics for Hyaluronic Acid in Healthcare
Figure 4 : Active Clinical Trials for Hyaluronic Acid, by Indication Type, 2025
Figure 5 : Global Market Shares of Hyaluronic Acid Medical Products, by Product, 2024
Figure 6 : Global Market Shares of Viscosupplements, by Regimen Type, 2024
Figure 7 : Global Market Shares of Ophthalmic Products, by Type, 2024
Figure 8 : Global Market Shares of Hyaluronic Acid Medical Products, by Hyaluronic Acid Source, 2024
Figure 9 : Global Market Shares of Hyaluronic Acid Medical Products, by Region, 2024
Figure 10 : North American Market Shares of Hyaluronic Acid Medical Products, by Product, 2024
Figure 11 : North American Market Shares of Hyaluronic Acid Medical Products, by Country, 2024
Figure 12 : European Market Shares of Hyaluronic Acid Medical Products, by Product, 2024
Figure 13 : European Market Shares of Hyaluronic Acid Medical Products, by Country, 2024
Figure 14 : Asia-Pacific Market Shares of Hyaluronic Acid Medical Products, by Product, 2024
Figure 15 : Asia-Pacific Market Shares of Hyaluronic Acid Medical Products, by Country, 2024
Figure 16 : MEA Market Shares of Hyaluronic Acid Medical Products, by Product, 2024
Figure 17 : South American Market Shares of Hyaluronic Acid Medical Products, by Product, 2024
Figure 18 : Global Market Shares of Hyaluronic Acid Dermal Fillers, by Company, 2024
Figure 19 : Global Market Shares of Viscosupplements, by Company, 2024
Figure 20 : AbbVie Inc.: Revenue Share, by Business Unit, FY 2024
Figure 21 : AbbVie Inc.: Revenue Share, by Country/Region, FY 2024
Figure 22 : Anika Therapeutics Inc.: Revenue Share, by Business Unit, FY 2024
Figure 23 : Anika Therapeutics Inc.: Revenue Share, by Country/Region, FY 2024
Figure 24 : Bioventus: Revenue Share, by Business Unit, FY 2024
Figure 25 : Bioventus: Revenue Share, by Country/Region, FY 2024
Figure 26 : Ferring B.V.: Revenue Share, by Business Unit, FY 2024
Figure 27 : Ferring B.V.: Revenue Share, by Country/Region, FY 2024
Figure 28 : Fidia Farmaceutici S.p.A.: Revenue Share, by Business Unit, FY 2024
Figure 29 : Fidia Farmaceutici S.p.A.: Revenue Share, by Country/Region, FY 2024
Figure 30 : Galderma: Revenue Share, by Business Unit, FY 2024
Figure 31 : Galderma: Revenue Share, by Country/Region, FY 2024
Figure 32 : Medytox: Revenue Share, by Business Unit, FY 2024
Figure 33 : Medytox: Revenue Share, by Country/Region, FY 2024
Figure 34 : Sanofi: Revenue Share, by Business Unit, FY 2024
Figure 35 : Sanofi: Revenue Share, by Country/Region, FY 2024
Figure 36 : Santen Pharmaceutical Co. Ltd.: Revenue Share, by Business Unit, FY 2024
Figure 37 : Santen Pharmaceutical Co. Ltd.: Revenue Share, by Country/Region, FY 2024
Figure 38 : Seikagaku Corp.: Revenue Share, by Business Unit, FY 2024
Figure 39 : Seikagaku Corp.: Revenue Share, by Country/Region, FY 2024
- Not Sure / Need Reassuring
- Confirm Content
-
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
-
- Sample Pages
-
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Check for Alternatives
-
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
-
- Confirm Content
- Prices / Formats / Delivery
- Prices
-
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Discounts
-
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Available Currencies
-
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
-
- Licenses
-
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Global Site License
-
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Formats
-
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
-
- Delivery
-
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
-
- Shipping Charges
-
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
-
- Prices
- Ordering
- By Credit Card
-
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
-
- By Money Transfer
-
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
-
- By Credit Card
- Security
- Website security
-
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
-
- Credit Card Security
-
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.
-
- Website security